Up Nearly 840% in a Year, Does This ‘Strong Buy’ Stock Have More Room to Run?

Summary

An analyst rates a stock that has appreciated nearly 840% over the past year as a 'strong buy,' suggesting potential for further gains. The article is a valuation commentary without specific clinical, regulatory, or financial catalysts.